Back to AZN Stock Lookup

AZN Related Corporate News

Jun 6, 2013 08:15 AM Isis Pharma (ISIS) Receives $6M from AstraZeneca (AZN) in Research Collaboration
Jun 4, 2013 09:06 AM Bristol-Myers (BMY), AstraZeneca (AZN) Receive FDA Priority Review Designation for Metreleptin
Jun 4, 2013 06:37 AM AstraZeneca (AZN) Will Not Proceed with Fostamatinib; Returns Rights to Rigel (RIGL)
Jun 3, 2013 02:02 PM Isis Pharma (ISIS) Presents Data from ISIS-STAT3Rx Phase 1 in Cancer
Jun 3, 2013 07:02 AM Isis Pharma (ISIS) Will Receive $10M Milestone from ISIS-ARRx Development (AZN)
May 28, 2013 06:05 AM AstraZeneca (AZN) to Acquire Omthera (OMTH) for $12.70/Share
Apr 5, 2013 06:32 AM AstraZeneca (AZN) Reports Statistically Significant Data from OSKIRA-1
Apr 3, 2013 06:34 AM Actavis (ACT) Receives Favorable Verdict in Generic Pulmicort Respules Patent Case
Apr 3, 2013 06:33 AM Actavis (ACT) Receives TRO on Sales of Pulmicort Respules
Apr 2, 2013 09:50 AM AstraZeneca (AZN) May Appeal Adverse Pulmicort Respules Litigation Verdict
Mar 21, 2013 08:18 AM AstraZeneca (AZN) Updates on Growth Strategies; Plans tor Headcount Reduction
Mar 21, 2013 07:57 AM AstraZeneca (AZN) Enters RNA Agreement with Moderna Therapeutics
Mar 18, 2013 09:11 AM AstraZeneca (AZN) to Relocate R&D Center; Sees $1.4B in One-Time Charges
Mar 5, 2013 07:07 AM Targacept (TRGT) Enters New Modulator Collaboration Agreement w/ AstraZeneca (AZN)
Feb 26, 2013 06:34 AM AstraZeneca (AZN) Issues Encouraging Update from High-Level KODIAC-08 Trial
Dec 17, 2012 09:19 AM AstraZeneca (AZN) Enters In-Lincensing Deal for Progenics' (PGNX) Clostridium Difficile Program
Dec 14, 2012 01:22 PM AstraZeneca (AZN) Receives Favorable Decision in Crestor Patent Appeal
Dec 13, 2012 07:37 AM AstraZeneca (AZN) Updates on OSKIRA-4 Top-Line Results; Did Not Meet Secondary Objective
Dec 11, 2012 07:47 AM Isis (ISIS) and AstraZeneca (AZN) Team to Develope RNA Therapeutics
Dec 5, 2012 08:55 AM Mylan (MYL) Launches Generic Version of Astra's (AZN) Atacand HCT
Dec 5, 2012 08:37 AM AstraZeneca (AZN) Updates on Overall Survival from FASLODEX CONFIRM
Nov 14, 2012 11:55 AM Bristol-Myers (BMY), AstraZeneca (AZN) Receive EC Approval for Forxiga
Nov 12, 2012 06:49 AM AstraZeneca (AZN) Reports Statistically Significant Phase III KODIAC Results
Oct 23, 2012 09:11 AM AstraZeneca (AZN), Ironwood (IRWD) Enter Linaclotide co-Development Agreement
Oct 17, 2012 08:06 AM AstraZeneca (AZN) Picks Charles River Labs (CRL) for DMPK Safety Assessment Work
Oct 8, 2012 07:59 AM AstraZeneca (AZN), Ardelyx Enter NH3 Inhibitor Licensing Program
Aug 13, 2012 04:46 PM Pfizer (PFE) Gains OTC Rights for NEXIUM; Will Pay Astra (AZN) $250M Upfront
Aug 9, 2012 07:46 AM Bristol-Myers (BMY), AstraZeneca (AZN) Make Initial $3.2B Payment to Amylin Pharma; AstraZeneca Exercises Rights Option
Aug 1, 2012 08:33 AM Watson Pharma (WPI) Receives FDA Approval for Generic Pulmicort RESPULES (AZN)
Jul 31, 2012 08:03 AM Intellipharmaceutics (IPCI), AstraZeneca (AZN) Enter Patent Settlement for Generic Seroquel XR
Jul 12, 2012 08:03 AM AstraZeneca (AZN) Acquires Neuroscience Assets from Mazzachusetts-Based Link Medicine
Jun 19, 2012 08:27 AM AstraZeneca (AZN), Rigel (RIGL) in Exclusive License Agreement for JAK Inhibitor R256
Jun 11, 2012 07:23 AM Bristol-Myers (BMY), AstraZeneca (AZN) Report Significant Data from Dapagliflozin Phase 3 in HbA1c Reduction for Type 2 Diabetes Patients
May 10, 2012 09:02 AM AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in Certain Asthma Patient Groups
Apr 30, 2012 09:02 AM AstraZeneca (AZN) Ends Pact with Targacept (TRGT) for TC-5214
Apr 18, 2012 12:00 PM Targacept (TRGT) Can Fail and Yet Still Win for Investors - Barron's
Apr 2, 2012 04:06 PM Amgen (AMGN), AstraZeneca (AZN) to Jointly Develop, Commercialize Clinical-Stage Inflammation Portfolio
Mar 28, 2012 04:19 PM Myriad (MYGN), Teva's Cephalon Enter BRCA Mutation Testing Agreement
Mar 28, 2012 08:07 AM Teva (TEVA) Launches Generic Seroquel Tabs in U.S. (AN)
Mar 28, 2012 07:31 AM Mylan (MYL) Unit Launches Generic Seroquel Tabs (AZN)
Mar 26, 2012 07:10 AM AstraZeneca (AZN) Denied Request for Preliminary Injunction in Generic Quetiapine/FDA Suit
Mar 26, 2012 07:09 AM AstraZeneca (AZN) Reports Results of BRILINTA Sub-Study at ACC 12
Mar 22, 2012 10:03 AM AstraZeneca's (AZN) BRILINTA Gets Tier 2 Access on Medco's Medicare Part D List
Mar 20, 2012 06:33 AM AstraZeneca (AZN), Targacept (TRGT) Will Not File for TC-5214 as Adjunct Treatment for MDD Patients
Mar 15, 2012 05:13 PM Mylan (MYL) Gets Aproval for Generic Crestor Tabs in Canada
Mar 13, 2012 06:27 AM AstraZeneca (AZN) Sues FDA Over SEROQUEL Citizen Petitions Denial
Feb 16, 2012 09:02 AM AstraZeneca (AZN), Espress Scripts (ESRX) Announce First D-T-P Program for ARIMIDEX Patients
Feb 8, 2012 09:01 AM AstraZeneca (AZN) Broadens AZ&Me Prescription Savings Programs Eligibility
Feb 2, 2012 07:18 AM AstraZeneca (AZN) Announces Restructuring, Will Eliminate 7,300 Positions
Feb 1, 2012 08:07 AM Impax (IPXL) Unit Licenses Zomig Rights in U.S. from AstraZeneca (AZN); Updates FY12 Outlook

Back to AZN Stock Lookup